Literature DB >> 16952698

Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?

Tufan Tarcan1, Fikret Fatih Onol, Yalcin Ilker, Ferruh Simsek, Ferruh Simek, Memet Ozek.   

Abstract

PURPOSE: The diagnostic criteria for secondary tethering of the spinal cord in children with prior closure of an open spinal defect are not well defined. Urological, neurological or orthopedic deterioration during followup remains the only strong indicator for the diagnosis of this condition. However, the outcome of untethering surgery cannot always be predicted. The aim of this study was to determine neurourological outcome after secondary untethering surgery in children with myelomeningocele.
MATERIALS AND METHODS: Of 401 children with myelomeningocele followed at our multidisciplinary spina bifida clinic between 1996 and 2005, 56 (14%) were diagnosed with secondary tethering of the spinal cord (median age at diagnosis 4.1 years). The diagnosis was based on urological and neuro-orthopedic deterioration in 58% and 42% of children, respectively. Preoperative urological findings were compared with 6-month postoperative findings.
RESULTS: Febrile urinary tract infection, upper tract dilatation and vesicoureteral reflux were preoperatively documented in 48.2%, 19% and 30% of the 56 children, respectively. At 6 months postoperatively urine cultures were sterile in 34% of patients and upper tract dilatation completely resolved in 45%. For all grades of vesicoureteral reflux complete resolution occurred in 47% of patients. Urodynamic parameters in terms of cystometric bladder capacity and detrusor leak point pressure substantially improved 6 months after untethering surgery (125 vs 170 ml and 69.1 vs 47.5 cm H2O, respectively, p < 0.05). Assessment of urodynamic findings in 19 children at 1 year failed to demonstrate a significant change in these parameters. A subgroup analysis according to patient age at untethering surgery revealed urodynamic improvement was more significant in children who were diagnosed and treated before age 7 years.
CONCLUSIONS: Secondary tethering of the spinal cord is a major risk factor for urological and neurological deterioration in children with myelomeningocele. Close urological surveillance remains the most valuable tool in the early diagnosis. Our study shows that secondary untethering surgery may significantly improve urological outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16952698     DOI: 10.1016/j.juro.2006.06.036

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Current approaches to the urologic care of children with spina bifida.

Authors:  David B Joseph
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

Review 2.  Who needs surgery for pediatric myelomeningocele? A retrospective study and literature review.

Authors:  Humberto Marreiros; Clara Loff; Eulália Calado
Journal:  J Spinal Cord Med       Date:  2014-07-16       Impact factor: 1.985

3.  Urodynamic outcomes of detethering in children: experience with 46 pediatric patients.

Authors:  Murat Geyik; Sırma Geyik; Haluk Şen; Serhat Pusat; Mehmet Alptekin; Ali Erdem Yılmaz; Mert Nazik; İbrahim Erkutlu
Journal:  Childs Nerv Syst       Date:  2016-03-11       Impact factor: 1.475

4.  Radiographic abnormalities, bladder interventions, and bladder surgery in the first decade of life in children with spina bifida.

Authors:  Adam J Rensing; Konrad M Szymanski; Rosalia Misseri; Joshua D Roth; Shelly King; Katherine Chan; Benjamin M Whittam; Martin Kaefer; Richard C Rink; Mark P Cain
Journal:  Pediatr Nephrol       Date:  2019-03-03       Impact factor: 3.714

5.  The role of urodynamic studies in the diagnosis and treatment of patients with spina bifida.

Authors:  I Alatas; H Demirci; Huseyin Canaz; O Akdemir; S Baydin; K Ozel
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

6.  Evaluation of Neurological Examination, SEP Results, MRI Results, and Lesion Levels in Patients Who Had Been Operated for Myelomeningocele.

Authors:  Gokhan Canaz; Huseyin Canaz; Ezgi T Erdogan; Ibrahim Alatas; Erhan Emel; Zeliha Matur
Journal:  J Pediatr Neurosci       Date:  2021-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.